KORU Medical Systems, Inc. $KRMD Shares Bought by Acuitas Investments LLC

Acuitas Investments LLC grew its holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD) by 89.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 763,088 shares of the company’s stock after acquiring an additional 360,594 shares during the period. Acuitas Investments LLC owned about 1.65% of KORU Medical Systems worth $2,923,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Police & Firemen s Retirement System of New Jersey purchased a new stake in shares of KORU Medical Systems during the second quarter valued at approximately $30,000. BNP Paribas Financial Markets raised its stake in KORU Medical Systems by 52.1% during the third quarter. BNP Paribas Financial Markets now owns 10,148 shares of the company’s stock valued at $39,000 after buying an additional 3,478 shares in the last quarter. Lazard Asset Management LLC bought a new position in KORU Medical Systems during the second quarter worth $59,000. Acadian Asset Management LLC bought a new position in shares of KORU Medical Systems in the 1st quarter worth about $63,000. Finally, Intech Investment Management LLC bought a new position in KORU Medical Systems in the second quarter worth about $73,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of KORU Medical Systems in a report on Thursday, January 22nd. Lake Street Capital lifted their price target on KORU Medical Systems from $6.00 to $8.00 and gave the company a “buy” rating in a research report on Monday, December 22nd. Canaccord Genuity Group reiterated a “buy” rating and issued a $6.00 target price on shares of KORU Medical Systems in a report on Friday, March 13th. Craig Hallum reaffirmed a “buy” rating and set a $7.00 target price on shares of KORU Medical Systems in a report on Tuesday, January 13th. Finally, Wall Street Zen downgraded shares of KORU Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, KORU Medical Systems presently has an average rating of “Moderate Buy” and an average price target of $6.50.

KORU Medical Systems Stock Performance

KRMD opened at $4.27 on Wednesday. The firm has a market cap of $198.00 million, a price-to-earnings ratio of -71.17 and a beta of 0.47. KORU Medical Systems, Inc. has a twelve month low of $1.86 and a twelve month high of $6.61. The firm’s 50-day simple moving average is $5.05 and its 200-day simple moving average is $4.80.

KORU Medical Systems (NASDAQ:KRMD) last posted its earnings results on Thursday, March 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.01. KORU Medical Systems had a negative net margin of 6.41% and a negative return on equity of 15.90%. The company had revenue of $10.90 million during the quarter, compared to analysts’ expectations of $10.90 million. As a group, sell-side analysts anticipate that KORU Medical Systems, Inc. will post -0.13 EPS for the current fiscal year.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.